USD 7.0
(0.0%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | - USD | 0.0% |
2022 | - USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2009 | 1.31 Million USD | 218.19% |
2008 | 414.41 Thousand USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 Q4 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2022 Q4 | - USD | 0.0% |
2022 Q3 | - USD | 0.0% |
2022 Q1 | - USD | 0.0% |
2022 Q2 | - USD | 0.0% |
2022 FY | - USD | 0.0% |
2021 Q4 | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2021 Q1 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2020 Q4 | - USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 FY | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2010 Q2 | 1.7 Million USD | 27.94% |
2010 Q1 | 1.32 Million USD | 1188338.75% |
2009 Q4 | 111.89 USD | 0.0% |
2009 FY | 1.31 Million USD | 218.19% |
2008 FY | 414.41 Thousand USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
America Great Health | 1.12 Million USD | 100.0% |
Gene Biotherapeutics, Inc. | - USD | NaN% |
Evolutionary Genomics, Inc. | 3.74 Million USD | 100.0% |
Innovation1 Biotech Inc. | 218.99 Thousand USD | 100.0% |
Point of Care Nano-Technology, Inc. | - USD | NaN% |